Litcius/Paper detail

HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study

Vivek Naranbhai, Mathias Viard, Michael Dean, Stefan Groha, David A. Braun, Chris Labaki, Sachet A. Shukla, Yuko Yuki, Parantu K. Shah, Kevin M. Chin, Megan Wind‐Rotolo, Xinmeng Jasmine Mu, Paul B. Robbins, Alexander Gusev, Toni K. Choueiri, James L. Gulley, Mary Carrington

2021The Lancet Oncology126 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOncologyInternal medicineCohortBiomarkerKidney cancerBladder cancerClinical trialEpidemiologyCancerImmunotherapyObservational studyImmunologyBiologyBiochemistryCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesTryptophan and brain disorders
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study | Litcius